Drug Discovery and Design
Health Science Center Publishes Research in Drug Discovery and Design
Published in Obesity and Diabetes Week, February 21st, 2011
2011 FEB 21 -- A new study, 'Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects,' is now available. According to a study from London, the United Kingdom, "Mammalian target of rapamycin (mTOR) inhibitors (mTORis) constitute a relatively new category of immunosuppressive and antineoplastic drugs. These share a unique mechanism of action that is focused on the inhibition of the mTOR."
"Their clinical applications have recently expanded significantly to cover a wide spectrum of immune and non-immune-mediated disorders, including, apart from solid organ transplantation, various solid organ and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Lancet
Country-by-country trends in obesity, cholesterol and blood pressure since 1980: Obesity has doubled, while Western wealthy countries have reduced blood pressure and cholesterol levels - Diabetes
Data from University of Michigan Provide New Insights into Diabetes - Cardiology
Findings from Medical Research Institute Advance Knowledge in Cardiology - Extracellular Matrix Proteins
Findings from Medical University of South Carolina Provide New Insights into Extracellular Matrix Proteins - Heart Disease
Lack of sleep found to be a new risk factor for colon cancer - Diabetes
New Diabetes Data Have Been Reported by Scientists at University of California - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
